The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCentaur Regulatory News (CAU)

Share Price Information for Centaur (CAU)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.50
Bid: 41.00
Ask: 42.00
Change: 0.00 (0.00%)
Spread: 1.00 (2.439%)
Open: 41.50
High: 41.80
Low: 41.50
Prev. Close: 41.50
CAU Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading update and accelerated simplification plan

25 Oct 2018 07:00

RNS Number : 1099F
Centaur Media PLC
25 October 2018
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014

 

25 October 2018

 

Centaur Media Plc

 

("Centaur " or "the Company")

 

Trading update and accelerated simplification plan

 

Centaur, an international provider of market intelligence and specialist consultancy, is today providing a trading update and revising its earnings guidance for the full year. The Company is also announcing a plan to create value for shareholders by exploring opportunities for further simplification by the divestment of select businesses.

 

For the year to 31 December 2018, the Board of Centaur expects to deliver adjusted operating profit of between £5.0-£5.5million which represents year-on-year growth* of 18% at the mid-point, although this is below current market expectations. The increase in profits reflects stronger performances from a number of the group's innovative, leading brands, notably The Lawyer and Marketing Week's Festival of Marketing and Mini MBA programme. With all events now complete, Centaur's exhibitions business has had a good year, and the financial services division has maintained its profitability at an increased margin.

 

Within Centaur's marketing division, both Econsultancy and MarketMakers have recently experienced delays in concluding certain enterprise contracts, which had been expected to contribute to 2018 revenues and profits. MarketMakers is expected to increase its revenues for the full year by 10%. Econsultancy's migration to our new technology platform has now been completed successfully but the delays have held back sales, and profits will be impacted.

 

The Board believes that Centaur has made substantial progress with its transformation in recent years, lessening its former reliance on advertising and print, developing subscription revenues and generating growth through new product development.

 

In recent months, Centaur has received approaches for a number of its assets from potential trade and private equity buyers who recognise the intrinsic value in these businesses, which operate in fast-changing market segments and where leading brands can fetch attractive valuations. The Board believes this value is not reflected in Centaur's current share price.

 

Following a strategic review, the Board has decided to accelerate the simplification of the group's structure by exploring the divestment of select businesses. The Board believes that making the group less complex will deliver operational benefits, generate central cost savings and help to focus attention on the leading brands within the marketing division.

 

Centaur is appointing advisors to assist the Board in conducting this process. It is the Board's intention to return surplus cash from divestments to shareholders in the most tax efficient manner.

 

Andria Vidler, Chief Executive, said: "Centaur has made good progress this year, it has improved its profits, it has strong cash flow and a solid balance sheet. We will now explore whether selective divestments could maximise shareholder value within the medium-term."

 

 

Contacts

 

Centaur Media - 0207 940 4000

Andria Vidler, Chief Executive Officer

Swag Mukerji, Chief Financial Officer

 

Teneo Blue Rubicon - 020 7420 3144

Paul Durman

Rosie Oddy

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTDMMZGGDFGRZZ
Date   Source Headline
19th Dec 202311:25 amRNSDirector/PDMR Shareholding
20th Nov 202311:22 amRNSDirector/PDMR Shareholding
26th Oct 20234:44 pmRNSDirector/PDMR Shareholding
22nd Sep 20239:30 amRNSDirector/PDMR Shareholding
20th Sep 20232:51 pmRNSDirector/PDMR Shareholding
19th Sep 202311:22 amRNSDirector/PDMR Shareholding
25th Aug 202311:00 amRNSDirector/PDMR Shareholding
21st Aug 202310:40 amRNSDirector/PDMR Shareholding
20th Jul 20237:00 amRNSInterim Results
17th Jul 20233:43 pmRNSDirector/PDMR Shareholding
21st Jun 20233:28 pmRNSDirector/PDMR Shareholding
1st Jun 202311:18 amRNSDirector Declaration
31st May 20234:35 pmRNSDirector Declaration
18th May 202311:44 amRNSDirector/PDMR Shareholding
10th May 20233:33 pmRNSResult of AGM
18th Apr 202311:47 amRNSDirector/PDMR Shareholding
12th Apr 20232:41 pmRNSDirector/PDMR Shareholding
4th Apr 20231:48 pmRNSAnnual Financial Report
21st Mar 20239:51 amRNSHolding(s) in Company
20th Mar 20233:33 pmRNSDirector/PDMR Shareholding
15th Mar 20237:00 amRNSPreliminary results for the year ended 31 Dec 2022
20th Feb 20239:30 amRNSDirector/PDMR Shareholding
31st Jan 20239:01 amRNSHolding(s) in Company
23rd Jan 20239:25 amRNSDirector/PDMR Shareholding
19th Jan 20237:00 amRNSTrading Update & Declaration of a Special Dividend
9th Jan 20234:40 pmRNSSecond Price Monitoring Extn
9th Jan 20234:35 pmRNSPrice Monitoring Extension
20th Dec 20222:19 pmRNSDirector/PDMR Shareholding
22nd Nov 20221:52 pmRNSDirector/PDMR Shareholding
16th Nov 20223:57 pmRNSDirector/PDMR Shareholding
24th Oct 20229:37 amRNSDirector/PDMR Shareholding
23rd Sep 202211:24 amRNSDirector/PDMR Shareholding
22nd Aug 20227:00 amRNSDirector/PDMR Shareholding
25th Jul 20225:13 pmRNSDirector/PDMR Shareholding
25th Jul 20229:50 amRNSDirector/PDMR Shareholding
20th Jul 20227:00 amRNSInterim Results
5th Jul 202210:30 amRNSDirector/PDMR Shareholding
23rd May 202210:33 amRNSDirector/PDMR Shareholding
16th May 20227:00 amRNSNon-Executive Director Appointment
12th May 202211:08 amRNSDirector/PDMR Shareholding
11th May 20223:09 pmRNSResult of AGM
21st Apr 202211:27 amRNSDirector/PDMR Shareholding
1st Apr 202211:54 amRNSAnnual Financial Report
25th Mar 202211:32 amRNSDirector/PDMR Shareholding
22nd Mar 20223:24 pmRNSDirector/PDMR Shareholding
18th Mar 20229:35 amRNSDirector/PDMR Shareholding
18th Mar 20229:31 amRNSHolding(s) in Company
16th Mar 20227:00 amRNSPreliminary results
22nd Feb 20223:03 pmRNSDirector/PDMR Shareholding
20th Jan 202210:59 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.